Trevi Therapeutics
TRVI
TRVI
182 hedge funds and large institutions have $1.63B invested in Trevi Therapeutics in 2025 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 75 increasing their positions, 48 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 163 → 182 (+19)
4.58% less ownership
Funds ownership: 106.2% → 101.61% (-4.6%)
29% less call options, than puts
Call options by funds: $5.3M | Put options by funds: $7.45M
Holders
182
Holding in Top 10
9
Calls
$5.3M
Puts
$7.45M
Top Buyers
| 1 | +$37M | |
| 2 | +$21.9M | |
| 3 | +$17.6M | |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$14.7M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$14.3M |
Top Sellers
| 1 | -$55.1M | |
| 2 | -$37.6M | |
| 3 | -$22.3M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$14M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$8.96M |
